EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Management of locally advanced non‐small cell lung cancer: State of the art and future directions

Da Miao, Jing Zhao, Ying Han, Jiaqi Zhou, Xiuzhen Li, Ting Zhang, Wen Li, Yang Xia iD

Cancer Communications · 2024-01 · 44 (1) · 23-46

DOI: 10.1002/cac2.12505 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Communications, online erschienen am 20.11.2023. Verfasst von Da Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zheji…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the second most common and the deadliest type of cancer worldwide. Clinically, non‐small cell lung cancer (NSCLC) is the most common pathological type of lung cancer; approximately one‐third of affected patients have locally advanced NSCLC (LA‐NSCLC, stage III NSCLC) at diagnosis. Because of its heterogeneity, LA‐NSCLC often requires multidisciplinary assessment. Moreover, the prognosis of affected patients is much below satisfaction, and the efficacy of traditional therapeutic strategies has reached a plateau. With the emergence of targeted therapies and immunotherapies, as well as the continuous development of novel radiotherapies, we have entered an era of novel treatment paradigm for LA‐NSCLC. Here, we reviewed the landscape of relevant therapeutic modalities, including adjuvant, neoadjuvant, and perioperative targeted and immune strategies in patients with resectable LA‐NSCLC with/without oncogenic alterations; as well as novel combinations of chemoradiation and immunotherapy/targeted therapy in unresectable LA‐NSCLC. We addressed the unresolved challenges that remain in the field, and examined future directions to optimize clinical management and increase the cure rate of LA‐NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansNeoplasm StagingCombined Modality TherapyPrognosis

Stichwörter der Autor:innen

adjuvant therapyimmunotherapylocally advancedneoadjuvant therapynon-small cell lung cancertargeted therapy

Autor:innen und Institutionen

  • Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China.
  • Department of Oncology, Shaoxing Second Hospital, Shaoxing, Zhejiang, P. R. China.
  • Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China.
  • Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, P. R. China.
  • Key Discipline of Jiaxing Respiratory Medicine Construction Project, Jiaxing Key Laboratory of Precision Treatment for Lung Cancer, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, P. R. China.
  • Department of Pathology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China.

ORCID-Profile: Yang Xia

Zitieren

APA

Miao, D., Zhao, J., Han, Y., Zhou, J., Li, X., Zhang, T., Li, W., & Xia, Y. (2024). Management of locally advanced non‐small cell lung cancer: State of the art and future directions. Cancer Communications, 44(1), 23-46. https://doi.org/10.1002/cac2.12505

Vancouver

Miao D, Zhao J, Han Y, Zhou J, Li X, Zhang T, et al. Management of locally advanced non‐small cell lung cancer: State of the art and future directions. Cancer Communications. 2024;44(1):23-46. doi:10.1002/cac2.12505

BibTeX
@article{Miao2024,
  author = {Miao, Da and Zhao, Jing and Han, Ying and Zhou, Jiaqi and Li, Xiuzhen and Zhang, Ting and Li, Wen and Xia, Yang},
  title = {Management of locally advanced non‐small cell lung cancer: State of the art and future directions},
  journal = {Cancer Communications},
  year = {2024},
  volume = {44},
  number = {1},
  pages = {23--46},
  doi = {10.1002/cac2.12505}
}
Kostenlos starten →